Oxidative Stress, Insulin Resistance and Cardiovascular Disease

The Metabolic Syndrome

Volumn , Issue , 2006, Pages 189-205

  Ceriello, Antonio ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Beta cell dysfunction; Beta cell mass and oxidative stress related tissue damage; Free radical overgeneration; Insulin resistance and T2DM; Mitochondrial electron transport chain; Oxidative stress in diabetes and CVD; Reduced intracellular antioxidant defense; Type 2 diabetes mellitus (T2DM)

Indexed keywords

EID: 82355185772     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470025131.ch7     Document Type: Chapter

References (89)

1. Amos, A., McCarthy, D., Zimmet, P. 1997. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med., 14 (Suppl. 5), S1-S85.
2. Balkau, B., Bertrais, S., Ducimetiere, P., Eschwege, E. 1999. Is there a glycaemic threshold for mortality risk? Diabetes Care, 22, 696-699.
3. Baron, A. D. 2002. Insulin resistance and vascular function. J. Diabetes Complic. 16, 92-102.
4. Bast, A., Wolf, G., Oberbaumer, I., Walther, R. 2002. Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia, 45, 867-876.
5. Bohlen, H. G., Lash, J. M. 1993. Topical hyperglycemia rapidly suppresses EDRF-medi-ated vasodilatation of normal rat arterioles. Am. J. Physiol., 265, H219-H225.
6. Brown, M. J., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T., Ruilope, L. M. 2000. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT). Lancet, 356, 366-372.
7. Bruce, C. R., Carey, A. L., Hawley, J. A., Febbraio, M. A. 2003. Intramuscolar heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defence mechanism. Diabetes, 52, 2338-2345.
8. Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., Azen, S. P. 2002. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes, 51, 2796-2803.
9. Carlsson, C., Borg, L. A., Welsh, N. 1999. Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology, 140, 3422-3428.
10. Ceriello, A. 1997. Acute hyperglycaemia and oxidative stress generation. Diabet. Med., 14 (Suppl. 3), S45-S49.
11. Ceriello, A. 2000. Oxidative stress and glycemic regulation. Metabolism, 49, 27-29.
12. Ceriello, A. 2003a. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia, 46 (Suppl. 1), M9-M16.
13. Ceriello, A. 2003b. New insights on oxidative stress and diabetic complications may lead to a 'causal' antioxidant therapy. Diabetes Care, 26, 1589-1596.
14. Ceriello, A., Motz, E. 2002. Angiotensin-receptor blockers, type 2 diabetes, and renoprotection. N. Engl. J. Med, 346, 705-707 (letter).
15. Ceriello, A., Morocutti, A., Mercuri, F., Quagliaro, L., Moro, M., Damante, G., Viberti, G. C. 2000. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes, 49, 2170-2177.
16. Ceriello, A., Taboga, C., Tonutti, L., Quagliaro, L., Piconi, L., Bais, B., Da Ros, R., Motz, E. 2002. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Effects of short-and long-term simvastatin treatment. Circulation, 106, 1211-1218.
17. Ceriello, A., Quagliaro, L., Catone, B., Pascon, R., Piazzola, M., Bais, B., Marra, G., Tonutti, L., Taboga, C., Motz, E. 2002b. The role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care, 25, 1439-1443.
18. Ceriello, A., Quagliaro, L., Piconi, L., Assaloni, R., Da Ros, R., Maier, A., Esposito, K., Giugliano, D. 2004. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes, 53, 701-710.
19. Chiasson, J. L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M. 2002. STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet, 359, 2072-2077.
20. Chiasson, J. L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M. 2003. STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA, 290, 486-494.
21. Cuzzocrea, S., Riley, D. P., Caputi, A. P., Salvemini, D. 2001. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev., 53, 135-159.
22. Da Ros, R., Assaloni, R., Ceriello, A. The preventive antioxidant action of thiazolinediones: a new therapeutic prospect in diabetes and insulin resistance. Diabet. Med., in press.
23. Dahlof, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., Lindholm, L. H., Nieminen, M. S., Omvik, P., Oparil, S., Wedel, H. 2002. LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet, 359, 995-1003.
24. Del Prato, S. 2003. Loss of early insulin secretion leads to postprandial hyperglycaemia. Diabetologia, 46, (Suppl. 1), M2-M8.
25. El-Assad, W., Buteau, J., Peyot, M. L., Nolan, C., Roduit, R., Hardy, S, et al. 2003. Saturated fatty acids synerize with elevated glucose to cause pancreatic beta-cell death. Endocrinology, 144, 4154-4163.
26. Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., Giugliano, D. 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation, 106, 2067-2072.
27. Evans, J. L., Goldfine, I. D., Maddux, B. A., Grodsky, G. M. 2003. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes, 52, 1-8.
28. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 285, 2486-2497.
29. Freeman, D. J., Norrie, J., Sattar, N., Neely, R. D., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., Packard, C. J., Shepherd, J., Gaw, A. 2001. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation, 103, 357-362.
30. Garcia Soriano, F., Virag, L., Jagtap, P., Szabo, E., Mabley, J. G., Liaudet, L., Marton, A., Hoyt, D. G., Murthy, K. G., Salzman, A. L., Southan, G. J., Szabo, C. 2001. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat. Med, 7, 108-113.
31. Giugliano, D., Ceriello, A., Paolisso, G. 1996. Oxidative stress and diabetic vascular complications. Diabetes Care, 19, 257-267.
32. Giugliano, D., Marfella, R., Coppola, L., Verrazzo, G., Acampora, R., Giunta, R., Nappo, F., Lucarelli, C., D'Onofrio, F. 1997. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation, 95, 1783-1790.
33. Griendling, K. K., FitzGerald, G. A. 2003. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation, 108, 1912-1916.
34. Haffner, S. M., Stern, M. P., Hazuda, H. P., Mitchell, B. D., Patterson, J. K. 1990. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA, 263, 2893-2898.
35. Heilbronn, L. K., Ravussin, E. 2003. Calorie restriction and aging: review of the literature and implications for studies in humans. Am. J. Clin. Nutr., 78, 361-369.
36. Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., Munzel, T. 2001. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation, 104, 2673-2678.
37. Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R. A. K., Warnholtz, A., Meinertz, T., Griendling, K., Harrison, D. G., Forstermann, U., Munzel, T. 2001. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res., 88, 14-22.
38. Hodgkinson, A. D., Bartlett, T., Oates, P. J., Millward, B. A., Demaine, A. G. 2003. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes, 52, 846-851.
39. Hu, F. B., Stampfer, M. J. 2003. Is type 2 diabetes mellitus a vascular condition? Arterioscler. Thromb. Vasc. Biol., 23, 1715-1716.
40. Hu, F. B., Stampfer, M. J., Haffner, S. M., Solomon, C. G., Willett, W. C., Manson, J. E. 2002. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care, 25, 1129-1134.
41. Jacqueminet, S., Briaud, I., Rouault, C., Reach, G., Poitout, V. 2002. Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metabolism, 49, 532-536.
42. Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., Creager, M. A. 1993. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation, 88, 2510-2516.
43. Kahan, S. E. 2003. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 46, 3-19.
44. Kannel, W. B., McGee, D. L. 1979. Diabetes and cardiovascular diseases. The Framingham Study. JAMA, 241, 2035-2038.
45. Kawano, H., Motoyama, T., Hirashima, O., Hirai, N., Miyao, Y., Sakamoto, T., Kugiyama, K., Ogawa, H., Yasue, H. 1999. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J. Am. Coll. Cardiol., 34, 146-154.
46. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., Nathan, D. M. 2002. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med., 346, 393-403.
47. Krauss, S., Zhang, C. Y., Scorrano, L., Dalgaard, L. T., St-Pierre, J., Grey, S. T., Lowell, B. B. 2003. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J. Clin. Invest., 112, 1831-1842.
48. Lakka, H. M., Laaksonen, D. E., Lakka, T. A., Niskanen, L. K., Kumpusalo, E., Tuomilehto, J., Salonen, J. T. 2002. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, 288, 2709-2716.
49. Lameloise, N., Muzzin, P., Prentki, M., Assimacopoulos-Jeannet, F. 2001. Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes, 50, 803-809.
50. Lane, N. 2003. A unifying view of ageing and disease: the double-agent theory. J. Theor. Biol., 225, 531-540.
51. Maddux, B. A., See, W., Lawrence, J. C. Jr., Goldfine, A. L., Goldfine, I. D., Evans, J. L. 2001. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes, 50, 404-410.
52. Maechler, P., Jornot, L., Wolheim, C. B. 1999. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J. Biol. Chem., 274, 27905-27913.
53. Marchioli, R., Schweiger, C., Levantesi, G., Gavazzi, L., Valagussa, F. 2001. Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids, 36, S53-S63.
54. Marfella, R., Verrazzo, G., Acampora, R., La Marca, C., Giunta, R., Lucarelli, C., Paolisso, G., Ceriello, A., Giugliano, D. 1995. Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects. Am. J. Physiol., 268, E1167-E1173.
55. Mason, R. P., Marche, P., Hintze, T. H. 2003. Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine. Arterioscler. Thromb. Vasc. Biol., 23, 2155-2163
56. Mayhan, W. G. 1989. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am. J. Physiol., 256, H621-H625.
57. McVeigh, G. E., Brennan, G. M., Johnston, G. D., McDermott, B. J., McGrath, L. T., Henry, W. R., Andrews, J. W., Hayes, J. R. 1992. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia, 35, 771-776.
58. Meraji, S., Jayakody, L., Senaratne, P. J., Thomson, A. B. R., Kappagoda, T. 1987. Endothelium-dependent relaxation in aorta of BB rat. Diabetes, 36, 978-981.
59. Münzel, T., Keaney, Jr, J. F. 2001. Are ACE inhibitors a 'magic bullet' against oxidative stress? Circulation, 104, 1571-1579.
60. Nappo, F., Esposito, K., Cioffi, M., Giugliano, G., Molinari, A. M., Paolisso, G., Marfella, R., Giugliano, D. 2002. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J. Am. Coll. Cardiol., 39, 1145-1150.
61. Nishikawa, T., Edelstein, D., Du, X.-L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M., Beebe, D., Oates, P., Hammes, H. P., Giardino, I., Brownlee, M. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404, 787-790.
62. Paolisso, G., Giugliano, D. 1996. Oxidative stress and insulin action. Is there a relationship? Diabetologia, 39, 357-363.
63. Paolisso, G., Giugliano, D., Pizza, G., Gambardella, A., Tesauro, P., Varricchio, M., D'Onofrio, F. 1992. Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care, 15, 1-7.
64. Paolisso, G., Gambardella, A., Tagliamonte, M. R., Saccomanno, F., Salvatore, T., Gualdiero, P., D'Onofrio, F., Howard, B. 1996. Does free fatty acid infusion impair insulin action also though an increase in oxidative stress? J. Clin. Endocrinol. Metab., 81, 4244-4248.
65. Perticone, F., Ceravolo, R., Pujia, A., Ventura, G., Iacopino, S., Scozzafava, A., Ferraro, A., Chello, M., Mastroroberto, P., Verdecchia, P., Schillaci, G. 2001. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation, 104, 191-196.
66. Piro, S., Anello, M., Di Pietro, C., Lizzio, M. N., Patane, G., Rabuazzo, A. M., Vigneri, R., Purrello, M., Purrello, F. 2002. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism, 51, 1340-1347.
67. Pleiner, J., Schaller, G., Mittermayer, F., Bayerle-Eder, M., Roden, M., Woltz, M. 2002. FFA-induced endothelial dysfunction can be corrected by vitamin C. J. Clin. Endocrinol. Metab, 87, 2913-2917.
68. Poitout, V., Robertson, R. P. 2002. Minireview: secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology, 143, 339-342.
69. Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y., Takahashi, H. 2003. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes, 52, 581-587.
70. Roebuck, K. A. 1999. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int. J. Mol. Med, 4, 223-230.
71. Rosembloom, A. L., Joe, J. R., Young, R. S., Winter, W. E. 1999. Emerging epidemic of type 2 diabetes in youth. Diabetes Care, 22, 345-354.
72. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for 1990s. Nature, 326, 801-809.
73. Rudich, A., Tirosh, A., Potashnik, R., Hemi, R., Kanety, H., Bashan, N. 1998. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes, 47, 1562-1569.
74. Sakai, K., Matsumoto, K., Nishikawa, T., Suefuji, M., Nakamaru, K., Hirashima, Y., Kawashima, J., Shirotani, T., Ichinose, K., Brownlee, M., Araki, E. 2003. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem. Biophys. Res. Commun., 300, 216-222.
75. Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., Yagihashi, S. 2002. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia, 45, 85-96.
76. Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., Sherwin, R. S., Caprio, S. 2002. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N. Engl. J. Med., 346, 802-810.
77. Smith, R. A., Porteous, C. M., Gane, A. M., Murphy, M. P. 2003. Delivery of bioactive molecules to mitochondria in vivo. Proc. Natl. Acad. Sci. USA, 100, 5407-5412.
78. Stern, M. P. 1995. Diabetes and cardiovascular disease. The 'common soil' hypothesis. Diabetes, 44, 369-374
79. Takemoto, M., Liao, J. K. 2001. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler. Thromb. Vasc. Biol., 21, 1712-1719.
80. Talior, I., Yarkoni, M., Bashan, N., Eldar-Fielman, H. 2003. Increased glucose uptake promotes oxidative stress and PKC delta activation in adipocytes of obese, insulin-resistant mice. Am. J. Physiol., 285, E295-E302.
81. Tesfamariam, B., Cohen, R. A. 1992. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol., 263, H321-H326.
82. Tiedge, M., Lortz, S., Drinkgern, J., Lenzen, S. 1997. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin producing cells. Diabetes, 46, 1733-1742.
83. Ting, H. H., Timimi, F. K., Boles, K. S., Creager, S. J., Ganz, P., Creager, M. A. 1996. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest., 97, 22-28.
84. Tretter, L., Adam-Vizi, V. 2000. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of alpha-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci., 20, 8972-8979.
85. Tripathy, D., Mohanty, P., Dhindsa, S., Syed, T., Ghanim, H., Aljada, A., Dandona, P. 2003. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes, 52, 2882-2887.
86. Tuomilehto, J., Lindstrom, J., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., Uusitupa, M. 2001. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med, 344, 1343-1350.
87. Vermes, E., Ducharme, A., Bourassa, M. G., Lessard, M., White, M., Tardif, J. C. 2003. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation, 107, 1291-1296.
88. Williamson, J. R., Cooper, R. H. 1980. Regulation of the citric acid cycle in mammalian systems. FEBS Lett, 117, (Suppl.), K73-K85.
89. Yusuf, S., Gerstein, H., Hoogwerf, B., Pogue, J., Bosch, J., Wolffenbuttel, B. H., Zinman, B. 2001. HOPE Study Investigators: Ramipril and the development of diabetes. JAMA, 286, 1882-1885.